|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 93 No. 1 (January 1), 1999:
pp. 15-24
RAPID COMMUNICATION
Identification of a Novel Stat3 Recruitment and Activation Motif Within
the Granulocyte Colony-Stimulating Factor Receptor
Arup Chakraborty,
Kevin F. Dyer,
Michael Cascio,
Timothy A. Mietzner, and
David J. Tweardy
From the Division of Infectious Diseases, the Departments of Medicine
and the Department of Molecular Genetics and Biochemistry, University
of Pittsburgh School of Medicine and the University of Pittsburgh
Cancer Institute, 200 Lothrop St, Pittsburgh, PA.
Stat3 is essential for early embryonic development and for myeloid
differentiation induced by the cytokines granulocyte colony-stimulating factor (G-CSF) and interleukin-6 (IL-6). Two isoforms of Stat3 have
been identified, (p92) and (p83), which have distinct transcriptional and biological functions. Activation of both Stat3 and Stat3 requires the distal cytoplasmic domain of the G-CSFR, which contains four Tyr at positions 704, 729, 744, and 764. The studies reported here were undertaken to determine which, if any, of
these tyrosine residues participated in Stat3 / recruitment and
activation. We showed that Stat3 and Stat3 were affinity purified
using phosphopeptides containing Y704 and Y744 but not by
nonphosphorylated peptide analogues or by phosphopeptides containing Y729 and Y764. Complementary results were obtained in studies examining
the ability of these peptides to destabilize and inhibit DNA binding of
activated Stat3. Both Y704 and Y744 contributed to optimal activation
of Stat3 / in M1 murine myeloid leukemia cells containing
wild-type and Y-to-F mutant G-CSFR constructs. Carboxy-terminal to Y704
at the +3 position is Gln; YXXQ represents a consensus Stat3
recruitment and activation motif. Y744 is followed at the +3 position
by Cys (C); YXXC, represents a novel motif implicated in the
recruitment and activation of Stat3. Modeling of the SH2 domain of
Stat3 based on homologous SH2 domains of known structure revealed polar
residues whose side chains contact the +3 position. This substitution
may confer specificity for the Y704- and Y744-based ligands by allowing
H-bond formation between the binding surface and the Gln or Cys found
at the respective +3 position.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Jiang, N. Hein, K. Eckert, J. Luscher-Firzlaff, and B. Luscher
Regulation of the MAD1 promoter by G-CSF
Nucleic Acids Res.,
March 1, 2008;
36(5):
1517 - 1531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tauzin, H. Ding, K. Khatib, I. Ahmad, D. Burdevet, G. van Echten-Deckert, J. A. Lindquist, B. Schraven, N.-u. Din, B. Borisch, et al.
Oncogenic association of the Cbp/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts
Blood,
February 15, 2008;
111(4):
2310 - 2320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Shao, X. Xu, N. Jing, and D. J. Tweardy
Unique structural determinants for stat3 recruitment and activation by the granulocyte colony-stimulating factor receptor at phosphotyrosine ligands 704 and 744.
J. Immunol.,
March 1, 2006;
176(5):
2933 - 2941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.-J. M. van de Geijn, J. Gits, L. H. J. Aarts, C. Heijmans-Antonissen, and I. P. Touw
G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact
Blood,
August 1, 2004;
104(3):
667 - 674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Shao, X. Xu, M.-A. A. Mastrangelo, N. Jing, R. G. Cook, G. B. Legge, and D. J. Tweardy
Structural Requirements for Signal Transducer and Activator of Transcription 3 Binding to Phosphotyrosine Ligands Containing the YXXQ Motif
J. Biol. Chem.,
April 30, 2004;
279(18):
18967 - 18973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Shao, H. Y. Cheng, R. G. Cook, and D. J. Tweardy
Identification and Characterization of Signal Transducer and Activator of Transcription 3 Recruitment Sites within the Epidermal Growth Factor Receptor
Cancer Res.,
July 15, 2003;
63(14):
3923 - 3930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Benekli, M. R. Baer, H. Baumann, and M. Wetzler
Signal transducer and activator of transcription proteins in leukemias
Blood,
April 15, 2003;
101(8):
2940 - 2954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. A. Hermans, G.-J. van de Geijn, C. Antonissen, J. Gits, D. van Leeuwen, A. C. Ward, and I. P. Touw
Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells
Blood,
April 1, 2003;
101(7):
2584 - 2590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Ren and T. S. Schaefer
ErbB-2 Activates Stat3alpha in a Src- and JAK2-dependent Manner
J. Biol. Chem.,
October 4, 2002;
277(41):
38486 - 38493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Dong and D. J. Tweardy
Interactions of STAT5b-RARalpha , a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways
Blood,
April 15, 2002;
99(8):
2637 - 2646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Hevehan, W. M. Miller, and E. T. Papoutsakis
Differential expression and phosphorylation of distinct STAT3 proteins during granulocytic differentiation
Blood,
March 1, 2002;
99(5):
1627 - 1637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kirito, K. Nakajima, T. Watanabe, M. Uchida, M. Tanaka, K. Ozawa, and N. Komatsu
Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation
Blood,
January 1, 2002;
99(1):
102 - 110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Nakajima and J. N. Ihle
Granulocyte colony-stimulating factor regulates myeloid differentiation through CCAAT/enhancer-binding protein {epsilon}
Blood,
August 15, 2001;
98(4):
897 - 905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. Duarte and D. A. Frank
SCF and G-CSF lead to the synergistic induction of proliferation and gene expression through complementary signaling pathways
Blood,
November 15, 2000;
96(10):
3422 - 3430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Umeshita-Suyama, R. Sugimoto, M. Akaiwa, K. Arima, B. Yu, M. Wada, M. Kuwano, K. Nakajima, N. Hamasaki, and K. Izuhara
Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor {alpha} chain 1: redundancy of requirement of tyrosine residue for STAT3 activation
Int. Immunol.,
November 1, 2000;
12(11):
1499 - 1509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Ward, L. Smith, J. P. de Koning, Y. van Aesch, and I. P. Touw
Multiple Signals Mediate Proliferation, Differentiation, and Survival from the Granulocyte Colony-stimulating Factor Receptor in Myeloid 32D Cells
J. Biol. Chem.,
May 21, 1999;
274(21):
14956 - 14962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Zong, J. Chan, D. E. Levy, C. Horvath, H. B. Sadowski, and L.-H. Wang
Mechanism of STAT3 Activation by Insulin-like Growth Factor I Receptor
J. Biol. Chem.,
May 12, 2000;
275(20):
15099 - 15105.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|